Malignant Pleural Effusion (MPE) is considered to be a common presentation at malignant tumors representing 15% of all cancer cases. It carries a burden on our patients with dyspnea being the most common symptom in most of cases. Management of symptomatic malignant pleural effusion remains to be a point of debate. Data available from literature shows conflicting results lacking high quality evidence which necsscitates further research work. Options differs to include chemical pleurodesis using medical or surgical talc poudrage or slurry. Surgical intervention with abrasion pleurodesis or pleurectomy using VATS approach has been used in many studies. Using indwelling pleural catheters (IPCs) has also proved comparable efficacy at many clinical trials. In this study we want to help answering this question so that we can add to the current knowledge aiming to offer the best care for those patients
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
60
VATS drainage and surgical abrasion.
Tube drainage for malignant pleural effusion
Assiut university heart hospital
Asyut, Egypt
RECRUITINGTotal hospital stay
duration of hospital stay in days
Time frame: 3 months postoperative
duration of airleak
duration in days
Time frame: 3 months postoperative
Status of performance
patient reported outcome through a pre-prepared questionnaire
Time frame: 3 months
mortality
Rate of mortality
Time frame: '3 months
Failure of management
time to re-collection
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.